This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
The Zacks Analyst Blog Highlights: AstraZeneca, salesforce, Mastercard, Lam Research and Koninklijke
by Zacks Equity Research
The Zacks Analyst Blog Highlights: AstraZeneca, salesforce, Mastercard, Lam Research and Koninklijke
Top Analyst Reports for AstraZeneca, Salesforce & Mastercard
by Mark Vickery
Today's Research Daily features new research reports on 12 major stocks, including AstraZeneca (AZN), salesforce.com (CRM) and Mastercard (MA)
Philips Evolves as a Healthcare Company, Tariffs a Concern
by Zacks Equity Research
Koninklijke Philips (PHG) is gaining solid momentum as it further penetrates the healthcare market.
DKILY vs. PHG: Which Stock Is the Better Value Option?
by Zacks Equity Research
DKILY vs. PHG: Which Stock Is the Better Value Option?
Koninklijke Philips' (PHG) Q2 Earnings Up Y/Y, Sales Flat
by Zacks Equity Research
Koninklijke Philips' (PHG) second-quarter results benefit from robust performance in the Diagnosis & Treatment business.
Stock Market News For Jul 2, 2018
by Zacks Equity Research
Markets closed higher on Friday, the last trading session of the first half of the year, as energy stocks rallied.
LabCorp, Philips Tie Up to Advance in Digital Pathology
by Zacks Equity Research
Through the latest collaboration, LabCorp (LH) aims at strengthening its hold inthe high potential digital pathology market.
PHG vs. TRMB: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
PHG vs. TRMB: Which Stock Is the Better Value Option?
Philips EPD Buyout to Expand Image-Guided Therapy Portfolio
by Zacks Equity Research
Koninklijke Philips (PHG) is set to buy cardiac imaging and navigation system provider EPD solutions.
Philips (PHG) Reports Q1 Earnings, Comparable Order Intake Up
by Zacks Equity Research
Phillips' (PHG) first-quarter 2018 results benefit from its Diagnosis & Treatment businesses on the back of growth in Ultrasound, Diagnostic Imaging and Image-Guided Therapy.
Philips' Dual Use DRF System Gets FDA Nod for Marketing
by Zacks Equity Research
Koninklijke Philips's (PHG) new Digital Radiography-Fluoroscopy system receives approval of the U.S. Food and Drug Administration for marketing.
Philips Collaborates on Program for Medication Adherence
by Zacks Equity Research
Philips (PHG) joins forces with Partners Connected Health and Triad HealthCare Network for high quality patient care with lower cost of medical non-adherence.
Philips' (PHG) IntelliVue Guardian Enhances Patient Outcomes
by Zacks Equity Research
Philips (PHG) announces that Saratoga Hospital has successfully improved patient safety and clinical outcomes with the integration of Philips' IntelliVue Guardian.
Hologic's Alliance With Philips to Boost Breast Health Unit
by Zacks Equity Research
Hologic (HOLX) is consistently trying to fortify its Breast Health segment.
Philips (PHG) Reports Q4 Earnings, Order Intake Strong
by Zacks Equity Research
Driven by impressive sales growth in Personal Health and Diagnosis & Treatment businesses, Philips (PHG) reported decent results in fourth-quarter 2017 results.
Philips Inks Telehealth Partnership Deal With American Well
by Zacks Equity Research
Koninklijke Philips N.V.'s (PHG) professional and consumer digital health solutions to be combined with American Well's premium virtual care capabilities for upgrading the former's Avent uGrow application.
Philips' Vereos Digital PET/CT to Aid Clinique de Genolier
by Zacks Equity Research
Philips (PHG) announces successful installation of Vereos digital PET/CT system, in addition to its Ambient Experience solution in the Clinique de Genolier.
Philips Teams Up With HomeLab to Improve Indoor Air Quality
by Zacks Equity Research
Philips (PHG) announces its collaboration with HomeLab to create a healthy home environment that would incorporate Philips Air Purifier into HomeLab's Healthy Home Program.
Philips' Acquisition Spree Continues with VitalHealth Buy
by Zacks Equity Research
Philips (PHG) acquires VitalHealth in a bid to strengthen its foothold in the healthcare markets and its Forcare buyout will fortify its clinical informatics portfolio.
Philips Teams Up With 3D Systems, Stratasys for 3D Printing
by Zacks Equity Research
Philips (PHG) strengthened its advanced 3D-modeling capabilities by signing agreements with 3D Systems (DDD) and Stratasys (SSYS).
Philips' PerformanceBridge Practice to Aid Banner Health
by Zacks Equity Research
Philips (PHG) and Banner Health extend their multi-year partnership to include leverage of Philips' PerformanceBridge Practice in Banner's radiology departments.
Philips & Nuance Team Up to Bring AI in Radiology Reporting
by Zacks Equity Research
Philips (PHG) teams up with Nuance Communications (NUAN) to bring artificial intelligence-based image interpretation and reporting capabilities to radiologists.
New Strong Sell Stocks for November 7th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Philips (PHG) Q3 Earnings Increase Y/Y, Order Intake Strong
by Zacks Equity Research
Driven by impressive sales growth in Connected Care & Health Informatics businesses, Philips (PHG) reported modest growth in third-quarter 2017 results.
Philips Gets FDA Clearance to Market new eL18-4 Transducer
by Zacks Equity Research
Koninklijke Philips N.V. (PHG) announces that the U.S. Food and Drug Administration (FDA) has provided the 510(k) clearance to the company for marketing of the eL18-4 transducer.